Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Kreuter reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Galapagos, grants and personal fees from Roche, during the conduct of the study.
Conflict of interest: Dr. Lederer reports personal fees from Fibrogen, personal fees from Galapagos, personal fees from Roche, personal fees from Global Blood Therapeutics, personal fees from Sanofi Genzyme, personal fees from Veracyte, during the conduct of the study.
Conflict of interest: Dr. Cottin reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Roche, personal fees from Actelion, personal fees from Bayer, personal fees from Celgene, personal fees from Galapagos, personal fees from Gilead, personal fees from GlaxoSmithKline, personal fees from Merck Sharp & Dohme, personal fees from Novartis, personal fees from Promedior, personal fees from Sanofi, during the conduct of the study.
Conflict of interest: Dr. Kahn reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Roche, during the conduct of the study.
Conflict of interest: Dr. Ley reports personal fees from Roche/Genentech, during the conduct of the study.
Conflict of interest: Dr. Vancheri reports grants and personal fees from Boehringer Ingelheim, personal fees from Chiesi Farmaceutici , grants and personal fees from Roche, during the conduct of the study.
Conflict of interest: Dr. Weycker reports and Employee of Policy Analysis Inc. (PAI).
Conflict of interest: Dr. Atwood reports and Employee of Policy Analysis Inc. (PAI).
Conflict of interest: Dr. Kirchgaessler reports and Employee of F. Hoffmann-La Roche Ltd.
Conflict of interest: Dr. Ryerson reports grants and personal fees from Boehringer Ingelheim, grants and personal fees from Roche, during the conduct of the study.
This is a PDF-only article. Please click on the PDF link above to read it.
- Copyright ©ERS 2019